Inventor · disambiguated record
Robert B. Huizinga
Also filed as: HUIZINGA ROBERT B
2 granted patents·6 pending applications·6 citations·filing 2017–2025
47Inventor score
Files withAURINIA PHARMACEUTICALS INC8
Top patents by PatentIndex Score
8 records- 0175US10286036B2Protocol for treatment of lupus nephritisAURINIA PHARMACEUTICALS INC·Filed 2017·Granted May 14, 2019·6 cites·13 claims
- 0266US2023381271A1Protocol to minimize calcineurin inhibitor nephrotoxicityAURINIA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0365US11622991B2Protocol for treatment of lupus nephritisAURINIA PHARMACEUTICALS INC·Filed 2022·Granted Apr 11, 2023·0 cites·27 claims
- 0463US2024077469A1Protocol to minimize calcineurin inhibitor nephrotoxicityAURINIA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0562US2025042970A1B cell activating factor (baff)-a proliferation inducing ligand (april) dual inhibitorsAURINIA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0660US2025205303A1Protocol for treatment of lupus nephritisAURINIA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0757US2019224275A1Protocol for treatment of lupus nephritisAURINIA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0846US2023183293A1Methods of treating or preventing coronavirus infectionAURINIA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert B. Huizinga files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →